A detailed history of Royal Bank Of Canada transactions in Immutep LTD stock. As of the latest transaction made, Royal Bank Of Canada holds 87 shares of IMMP stock, worth $167. This represents 0.0% of its overall portfolio holdings.

Number of Shares
87
Previous 4,907 98.23%
Holding current value
$167
Previous $9,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.77 - $2.64 $8,531 - $12,724
-4,820 Reduced 98.23%
87 $0
Q2 2024

Aug 14, 2024

SELL
$1.87 - $3.23 $39,434 - $68,114
-21,088 Reduced 81.12%
4,907 $9,000
Q1 2024

Nov 05, 2024

BUY
$2.11 - $2.89 $44,495 - $60,944
21,088 Added 429.75%
25,995 $60,000
Q1 2024

May 15, 2024

BUY
$2.11 - $2.89 $54,710 - $74,934
25,929 Added 39286.36%
25,995 $60,000
Q4 2023

Feb 14, 2024

BUY
$1.76 - $2.49 $116 - $164
66 New
66 $0
Q4 2022

Feb 14, 2023

BUY
$1.6 - $2.53 $25 - $40
16 New
16 $0

Others Institutions Holding IMMP

About IMMUTEP Ltd


  • Ticker IMMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,000
  • Market Cap $167M
  • Description
  • Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...
More about IMMP
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.